We’ve received FDA clearance for the Elecsys® pTau217 blood test, which can help bring clinical clarity to Alzheimer’s assessment. With validated cutoffs across primary and specialty care, we’re expanding diagnostic access so providers can act earlier: go.roche.com/ptau217-pr
